[go: up one dir, main page]

PE20090624A1 - Diaminopirimidinas - Google Patents

Diaminopirimidinas

Info

Publication number
PE20090624A1
PE20090624A1 PE2008000379A PE2008000379A PE20090624A1 PE 20090624 A1 PE20090624 A1 PE 20090624A1 PE 2008000379 A PE2008000379 A PE 2008000379A PE 2008000379 A PE2008000379 A PE 2008000379A PE 20090624 A1 PE20090624 A1 PE 20090624A1
Authority
PE
Peru
Prior art keywords
pyrimidin
amino
compounds
metoxy
alcoxy
Prior art date
Application number
PE2008000379A
Other languages
English (en)
Inventor
Michael Patrick Dillon
Daisy Joe Du Bois
Alam Jahangir
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20090624A1 publication Critical patent/PE20090624A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE DIAMINOPIRIMIDINAS DE FORMULA (I) DONDE R1 ES ALCOXI(C1-C6), HIDROXI O HALOGENO; R2 ES ALCOXI(C1-C6), HALOGENO, ALQUILSULFONILO(C1-C6) O AMINOSULFONILO. SON COMPUESTOS PREFERIDOS: 2-[4-AMINO-5-(5-YODO-2-ISOPROPIL-4-METOXI-FENOXI)-PIRIMIDIN-2-ILAMINO]-PROPANO-1,3-DIOL, 5-[4-AMINO-2-(2-HIDROXI-1-HIDROXIMETIL-ETILAMINO)-PIRIMIDIN-5-ILOXI]-4-ISOPROPIL-2-METOXI-BENCENOSULFONAMIDA, 2-[4-AMINO-5-(4-CLORO-5-YODO-2-ISOPROPIL-FENOXI)-PIRIMIDIN-2-ILAMINO]-PROPANO-1,3-DIOL, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCESO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON MODULADORES DE LOS RECEPTORES PURINERGICOS P2X SIENDO UTILES EN EL TRATAMIENTO DE INCONTINENCIA, HIPERTROFIA BENIGNA DE PROSTATA, VEJIGA HIPERACTIVA, CISTITIS, NEURALGIAS
PE2008000379A 2007-02-28 2008-02-25 Diaminopirimidinas PE20090624A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90407907P 2007-02-28 2007-02-28

Publications (1)

Publication Number Publication Date
PE20090624A1 true PE20090624A1 (es) 2009-05-16

Family

ID=39297415

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000379A PE20090624A1 (es) 2007-02-28 2008-02-25 Diaminopirimidinas

Country Status (6)

Country Link
US (1) US20080207655A1 (es)
AR (1) AR065477A1 (es)
CL (1) CL2008000554A1 (es)
PE (1) PE20090624A1 (es)
TW (1) TW200845995A (es)
WO (1) WO2008104474A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5128603B2 (ja) * 2006-10-04 2013-01-23 エフ．ホフマン−ラ ロシュ アーゲー フェノキシジアミノピリミジン誘導体の合成方法
US8785694B2 (en) 2012-06-05 2014-07-22 Connora Technologies, Inc Processes for the preparation of di-(2-aminoethyl) formal, di-(3-aminopropyl) formal, and related molecules
NZ716977A (en) * 2013-08-23 2017-09-29 Afferent Pharmaceuticals Inc Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of acute and sub-acute cough, urge to cough and chronic cough, in respiratory diseases
WO2017058645A1 (en) * 2015-09-29 2017-04-06 Afferent Pharmaceuticals, Inc. Diaminopyrimidine p2x3 and p2x2/3 receptor modulators for use in the treatment of cough
US10822311B2 (en) 2016-03-14 2020-11-03 Afferent Pharmaceuticals, Inc. Pyrimidines and variants thereof, and uses therefor
MX384368B (es) * 2016-03-25 2025-03-14 Afferent Pharmaceuticals Inc Pirimidinas y sus variantes, y usos de las mismas.
CA3046027A1 (en) * 2016-12-20 2018-06-28 Prabha Ibrahim Crystalline salts and polymorphs of a p2x3 antagonist
US11124473B2 (en) 2017-07-11 2021-09-21 Aditya Birla Chemicals (Usa) Llc Salts of diaminoacetals and diaminoketals and their synthesis, and their transformations to diaminoacetals and diaminoketals
CN114007620B (zh) * 2019-04-30 2024-08-06 北京泰德制药股份有限公司 二氨基嘧啶类化合物治疗子宫内膜异位相关的疼痛的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2557372C (en) * 2004-03-05 2013-01-08 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 antagonists
ES2562056T3 (es) * 2005-09-01 2016-03-02 F. Hoffmann-La Roche Ag Diaminopirimidinas como moduladores P2X3 y P2X2/3
PL1924264T3 (pl) * 2005-09-01 2014-03-31 Hoffmann La Roche Diaminopirymidyny jako modulatory P2X<sub>3</sub> I P2X<sub>2/3</sub>
JP4850911B2 (ja) * 2005-09-01 2012-01-11 エフ．ホフマン−ラ ロシュ アーゲー Ｐ２ｘ３およびｐ２ｘ２／３モジュレーターとしてのジアミノピリミジン

Also Published As

Publication number Publication date
CL2008000554A1 (es) 2008-08-29
US20080207655A1 (en) 2008-08-28
WO2008104474A1 (en) 2008-09-04
AR065477A1 (es) 2009-06-10
TW200845995A (en) 2008-12-01

Similar Documents

Publication Publication Date Title
PE20090624A1 (es) Diaminopirimidinas
PE20080697A1 (es) Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
PE20070427A1 (es) Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas
UY32409A (es) Compuesto de anillo fusionado y su uso
NO20081034L (no) Pyrimidinforbindelser som serotoninreseptormodulatorer
EA200800726A1 (ru) Введение ингибиторов дипептидилпептидазы
PE20060530A1 (es) Aril y heteroaril derivados sustituidos como moduladores del metabolismo de la glucosa
GT200800305A (es) Moduladores del metabolismo y tratamiento de los desordenes metabolicos
GT200800158A (es) Pirazolquinolonas como potentes inhibidores de parp
BR112012017062A2 (pt) &#34;composições deterfgentes contendo lipase de geobacillus stearothermophilus e métodos para uso das mesmas&#34;
PE20120002A1 (es) Derivados de benceno sustituido con glucopiranosilo como inhibidores de sglt2
PE20080948A1 (es) Derivados de imidazol como moduladores de la senda de hedgehog
EA200970519A1 (ru) Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения
EA201170151A1 (ru) Пиперидиниловые агонисты gpcr
PE20060857A1 (es) Derivados de piridinilo y pirimidinilo sustituidos como moduladores del metabolismo y para tratar trastornos metabolicos
PE20080065A1 (es) Compuestos derivados de bencimidazol como moduladores del receptor vainilloide vr1
EA201100978A1 (ru) Схема приема агониста рецептора s1p
PA8658301A1 (es) Derivados fusionados de pirazol y metodos de tratamiento de trastornos metabolicos con estos
CR20110318A (es) Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos
PE20091450A1 (es) INHIBIDORES DE LA ESTEAROIL-CoA-DESATURASA
PE20141940A1 (es) Compuestos triciclicos, composiciones que los comprenden y usos de los mismos
CL2007001748A1 (es) Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras.
CL2008002826A1 (es) Compuestos derivados de pirimidina alquiltio sustituidas, antagonista crth2; composicion farmaceutica que comprende a dicho compuestos; y uso para tratar una enfermedad alergica, asma, dermatitis atopica, psoriasis, colitis ulcerantes, sinusitis, leucemia basofilica, entre otras.
PE20090999A1 (es) Nuevos derivados de metil-bencimidazol
CR11860A (es) Derivados de dibenzotiazepina y sus usos - 424

Legal Events

Date Code Title Description
FC Refusal